Target type: biologicalprocess
Any process that stops, prevents or reduces the frequency, rate or extent of tumor necrosis factor superfamily cytokine production. [GO_REF:0000058, GOC:TermGenie, PMID:24187568]
Negative regulation of tumor necrosis factor superfamily cytokine production is a complex biological process that involves multiple signaling pathways and regulatory mechanisms. The tumor necrosis factor (TNF) superfamily comprises a diverse group of transmembrane proteins that play crucial roles in immune responses, inflammation, and cell survival. These cytokines, upon binding to their cognate receptors, activate downstream signaling cascades that trigger a variety of cellular responses, including apoptosis, inflammation, and cell proliferation. Excessive or dysregulated production of TNF superfamily cytokines can contribute to the development of various diseases, including autoimmune disorders, inflammatory bowel disease, and cancer. Therefore, tightly regulated control over the production of these cytokines is essential for maintaining homeostasis.
The negative regulation of TNF superfamily cytokine production involves multiple layers of control, including:
1. **Transcriptional Regulation:**
- **NF-κB Inhibition:** The transcription factor NF-κB is a key regulator of TNF superfamily gene expression. Several inhibitory proteins, such as IκBα and A20, can block NF-κB activation and thus suppress TNF superfamily cytokine production.
- **STAT Signaling Inhibition:** Signal transducer and activator of transcription (STAT) proteins also play a role in regulating TNF superfamily gene expression. STAT inhibitors, such as SOCS proteins, can suppress STAT signaling and dampen TNF superfamily cytokine production.
2. **Post-Transcriptional Regulation:**
- **mRNA Stability:** MicroRNAs (miRNAs) can bind to target mRNAs and promote their degradation or inhibit their translation. Certain miRNAs have been shown to target TNF superfamily mRNAs, leading to decreased protein levels.
- **Protein Degradation:** The ubiquitin-proteasome system and autophagy are major pathways involved in protein degradation. TNF superfamily cytokines can be targeted for degradation through these pathways, thereby regulating their levels.
3. **Signal Transduction Inhibition:**
- **Receptor Antagonists:** Soluble decoy receptors and antibodies can bind to TNF superfamily cytokines and prevent their interaction with their cognate receptors, effectively blocking signaling.
- **Downstream Signaling Inhibitors:** Various signaling molecules, including kinases, phosphatases, and adaptor proteins, can regulate the downstream signaling pathways activated by TNF superfamily receptors. Inhibiting these molecules can dampen the pro-inflammatory and pro-apoptotic responses triggered by these cytokines.
4. **Cellular Mechanisms:**
- **Apoptosis:** Certain TNF superfamily cytokines, such as TNF-α, can induce apoptosis in target cells. This mechanism can limit the production of pro-inflammatory cytokines and prevent excessive inflammation.
- **Immune Suppression:** Regulatory T cells (Tregs) and other immune cells can suppress the production of TNF superfamily cytokines by producing inhibitory cytokines or by directly interacting with other immune cells.
In summary, the negative regulation of TNF superfamily cytokine production is a multi-faceted process that involves a complex interplay of transcriptional, post-transcriptional, and signaling pathways. The tight control over the production of these cytokines is essential for maintaining immune homeostasis and preventing the development of various diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Programmed cell death 1 ligand 1 | A programmed cell death 1 ligand 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q9NZQ7] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
sesamin | (+)-sesamin : A lignan that consists of tetrahydro-1H,3H-furo[3,4-c]furan substituted by 1,3-benzodioxole groups at positions 1 and 4 (the 1S,3aR,4S,6aR stereoisomer). Isolated from Cinnamomum camphora, it exhibits cytotoxic activity. | benzodioxoles; furofuran; lignan | antineoplastic agent; neuroprotective agent; plant metabolite |
pomalidomide | 3-aminophthalimidoglutarimide: structure in first source | aromatic amine; dicarboximide; isoindoles; piperidones | angiogenesis inhibitor; antineoplastic agent; immunomodulator |
apiin | apiin : A beta-D-glucoside having a beta-D-apiosyl residue at the 2-position and a 5,4'-dihydroxyflavon-7-yl moiety at the anomeric position. apiin: structure | beta-D-glucoside; dihydroxyflavone; glycosyloxyflavone | EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; plant metabolite |
fosbretabulin | stilbenoid |